Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Envoy Medical (COCH) Shares Outstanding (2021 - 2026)

Envoy Medical's Shares Outstanding history spans 6 years, with the latest figure at $368694.0 for Q1 2026.

  • On a quarterly basis, Shares Outstanding fell 98.27% to $368694.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $368694.0, a 98.27% decrease, with the full-year FY2025 number at $28.9 million, up 601.17% from a year prior.
  • Shares Outstanding hit $76.9 million in Q1 2026 for Envoy Medical, up from $28.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding for COCH hit a ceiling of $76.9 million in Q1 2026 and a floor of $4.1 million in Q1 2025.
  • Historically, Shares Outstanding has averaged $16.8 million across 5 years, with a median of $10.1 million in 2022.
  • Biggest five-year swings in Shares Outstanding: soared 601.17% in 2025 and later tumbled 98.27% in 2026.
  • Tracing COCH's Shares Outstanding over 5 years: stood at $10.1 million in 2022, then crashed by 55.54% to $4.5 million in 2023, then fell by 8.3% to $4.1 million in 2024, then soared by 601.17% to $28.9 million in 2025, then tumbled by 98.73% to $368694.0 in 2026.
  • Business Quant data shows Shares Outstanding for COCH at $368694.0 in Q1 2026, $28.9 million in Q4 2025, and $23.8 million in Q3 2025.